世界のEPOバイオマーカー市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global EPO Biomarkers Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2241 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、EPOバイオマーカーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（エリスロポエチンアルファ、エリスロポエチンベータ、エリスロポエチンゼータ、エリスロポエチンシータ、組換えヒトエリスロポエチン、ダルベポエチンアルファ）、用途別市場規模（診断センター、外来診療・外科センター、病院）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・EPOバイオマーカーの市場動向 ・企業の競争状況、市場シェア ・EPOバイオマーカーの種類別市場規模（エリスロポエチンアルファ、エリスロポエチンベータ、エリスロポエチンゼータ、エリスロポエチンシータ、組換えヒトエリスロポエチン、ダルベポエチンアルファ） ・EPOバイオマーカーの用途別市場規模（診断センター、外来診療・外科センター、病院） ・EPOバイオマーカーの北米市場規模2016-2027（アメリカ、カナダ） ・EPOバイオマーカーのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・EPOバイオマーカーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・EPOバイオマーカーの中南米市場規模2016-2027（メキシコ、ブラジル） ・EPOバイオマーカーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Siemens、Thermo Fisher Scientific、Pfizer、Novartis、Johnson & Johnson、Merck、LG Life Sciences India、Amgen、Roche、Agilent） ・結論

Market Analysis and Insights: Global EPO Biomarkers Market
The global EPO Biomarkers market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global EPO Biomarkers market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global EPO Biomarkers market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global EPO Biomarkers market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global EPO Biomarkers market.

Global EPO Biomarkers Scope and Market Size
EPO Biomarkers market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global EPO Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Erythropoietin alfa
Erythropoietin beta
Erythropoietin zeta
Erythropoietin theta
Recombinant human erythropoietin
Darbepoietin alfa

Segment by Application
Diagnostic centers
Ambulatory care and surgical centers
Hospitals

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Siemens
Thermo Fisher Scientific
Pfizer
Novartis
Johnson & Johnson
Merck
LG Life Sciences India
Amgen
Roche

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global EPO Biomarkers Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Erythropoietin alfa
1.2.3 Erythropoietin beta
1.2.4 Erythropoietin zeta
1.2.5 Erythropoietin theta
1.2.6 Recombinant human erythropoietin
1.2.7 Darbepoietin alfa
1.3 Market by Application
1.3.1 Global EPO Biomarkers Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostic centers
1.3.3 Ambulatory care and surgical centers
1.3.4 Hospitals
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global EPO Biomarkers Market Perspective (2016-2027)
2.2 EPO Biomarkers Growth Trends by Regions
2.2.1 EPO Biomarkers Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 EPO Biomarkers Historic Market Share by Regions (2016-2021)
2.2.3 EPO Biomarkers Forecasted Market Size by Regions (2022-2027)
2.3 EPO Biomarkers Industry Dynamic
2.3.1 EPO Biomarkers Market Trends
2.3.2 EPO Biomarkers Market Drivers
2.3.3 EPO Biomarkers Market Challenges
2.3.4 EPO Biomarkers Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top EPO Biomarkers Players by Revenue
3.1.1 Global Top EPO Biomarkers Players by Revenue (2016-2021)
3.1.2 Global EPO Biomarkers Revenue Market Share by Players (2016-2021)
3.2 Global EPO Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by EPO Biomarkers Revenue
3.4 Global EPO Biomarkers Market Concentration Ratio
3.4.1 Global EPO Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by EPO Biomarkers Revenue in 2020
3.5 EPO Biomarkers Key Players Head office and Area Served
3.6 Key Players EPO Biomarkers Product Solution and Service
3.7 Date of Enter into EPO Biomarkers Market
3.8 Mergers & Acquisitions, Expansion Plans

4 EPO Biomarkers Breakdown Data by Type
4.1 Global EPO Biomarkers Historic Market Size by Type (2016-2021)
4.2 Global EPO Biomarkers Forecasted Market Size by Type (2022-2027)

5 EPO Biomarkers Breakdown Data by Application
5.1 Global EPO Biomarkers Historic Market Size by Application (2016-2021)
5.2 Global EPO Biomarkers Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America EPO Biomarkers Market Size (2016-2027)
6.2 North America EPO Biomarkers Market Size by Type
6.2.1 North America EPO Biomarkers Market Size by Type (2016-2021)
6.2.2 North America EPO Biomarkers Market Size by Type (2022-2027)
6.2.3 North America EPO Biomarkers Market Size by Type (2016-2027)
6.3 North America EPO Biomarkers Market Size by Application
6.3.1 North America EPO Biomarkers Market Size by Application (2016-2021)
6.3.2 North America EPO Biomarkers Market Size by Application (2022-2027)
6.3.3 North America EPO Biomarkers Market Size by Application (2016-2027)
6.4 North America EPO Biomarkers Market Size by Country
6.4.1 North America EPO Biomarkers Market Size by Country (2016-2021)
6.4.2 North America EPO Biomarkers Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe EPO Biomarkers Market Size (2016-2027)
7.2 Europe EPO Biomarkers Market Size by Type
7.2.1 Europe EPO Biomarkers Market Size by Type (2016-2021)
7.2.2 Europe EPO Biomarkers Market Size by Type (2022-2027)
7.2.3 Europe EPO Biomarkers Market Size by Type (2016-2027)
7.3 Europe EPO Biomarkers Market Size by Application
7.3.1 Europe EPO Biomarkers Market Size by Application (2016-2021)
7.3.2 Europe EPO Biomarkers Market Size by Application (2022-2027)
7.3.3 Europe EPO Biomarkers Market Size by Application (2016-2027)
7.4 Europe EPO Biomarkers Market Size by Country
7.4.1 Europe EPO Biomarkers Market Size by Country (2016-2021)
7.4.2 Europe EPO Biomarkers Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific EPO Biomarkers Market Size (2016-2027)
8.2 Asia-Pacific EPO Biomarkers Market Size by Type
8.2.1 Asia-Pacific EPO Biomarkers Market Size by Type (2016-2021)
8.2.2 Asia-Pacific EPO Biomarkers Market Size by Type (2022-2027)
8.2.3 Asia-Pacific EPO Biomarkers Market Size by Type (2016-2027)
8.3 Asia-Pacific EPO Biomarkers Market Size by Application
8.3.1 Asia-Pacific EPO Biomarkers Market Size by Application (2016-2021)
8.3.2 Asia-Pacific EPO Biomarkers Market Size by Application (2022-2027)
8.3.3 Asia-Pacific EPO Biomarkers Market Size by Application (2016-2027)
8.4 Asia-Pacific EPO Biomarkers Market Size by Region
8.4.1 Asia-Pacific EPO Biomarkers Market Size by Region (2016-2021)
8.4.2 Asia-Pacific EPO Biomarkers Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America EPO Biomarkers Market Size (2016-2027)
9.2 Latin America EPO Biomarkers Market Size by Type
9.2.1 Latin America EPO Biomarkers Market Size by Type (2016-2021)
9.2.2 Latin America EPO Biomarkers Market Size by Type (2022-2027)
9.2.3 Latin America EPO Biomarkers Market Size by Type (2016-2027)
9.3 Latin America EPO Biomarkers Market Size by Application
9.3.1 Latin America EPO Biomarkers Market Size by Application (2016-2021)
9.3.2 Latin America EPO Biomarkers Market Size by Application (2022-2027)
9.3.3 Latin America EPO Biomarkers Market Size by Application (2016-2027)
9.4 Latin America EPO Biomarkers Market Size by Country
9.4.1 Latin America EPO Biomarkers Market Size by Country (2016-2021)
9.4.2 Latin America EPO Biomarkers Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa EPO Biomarkers Market Size (2016-2027)
10.2 Middle East & Africa EPO Biomarkers Market Size by Type
10.2.1 Middle East & Africa EPO Biomarkers Market Size by Type (2016-2021)
10.2.2 Middle East & Africa EPO Biomarkers Market Size by Type (2022-2027)
10.2.3 Middle East & Africa EPO Biomarkers Market Size by Type (2016-2027)
10.3 Middle East & Africa EPO Biomarkers Market Size by Application
10.3.1 Middle East & Africa EPO Biomarkers Market Size by Application (2016-2021)
10.3.2 Middle East & Africa EPO Biomarkers Market Size by Application (2022-2027)
10.3.3 Middle East & Africa EPO Biomarkers Market Size by Application (2016-2027)
10.4 Middle East & Africa EPO Biomarkers Market Size by Country
10.4.1 Middle East & Africa EPO Biomarkers Market Size by Country (2016-2021)
10.4.2 Middle East & Africa EPO Biomarkers Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Siemens
11.1.1 Siemens Company Details
11.1.2 Siemens Business Overview
11.1.3 Siemens EPO Biomarkers Introduction
11.1.4 Siemens Revenue in EPO Biomarkers Business (2016-2021)
11.1.5 Siemens Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific EPO Biomarkers Introduction
11.2.4 Thermo Fisher Scientific Revenue in EPO Biomarkers Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer EPO Biomarkers Introduction
11.3.4 Pfizer Revenue in EPO Biomarkers Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis EPO Biomarkers Introduction
11.4.4 Novartis Revenue in EPO Biomarkers Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson EPO Biomarkers Introduction
11.5.4 Johnson & Johnson Revenue in EPO Biomarkers Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck EPO Biomarkers Introduction
11.6.4 Merck Revenue in EPO Biomarkers Business (2016-2021)
11.6.5 Merck Recent Development
11.7 LG Life Sciences India
11.7.1 LG Life Sciences India Company Details
11.7.2 LG Life Sciences India Business Overview
11.7.3 LG Life Sciences India EPO Biomarkers Introduction
11.7.4 LG Life Sciences India Revenue in EPO Biomarkers Business (2016-2021)
11.7.5 LG Life Sciences India Recent Development
11.8 Amgen
11.8.1 Amgen Company Details
11.8.2 Amgen Business Overview
11.8.3 Amgen EPO Biomarkers Introduction
11.8.4 Amgen Revenue in EPO Biomarkers Business (2016-2021)
11.8.5 Amgen Recent Development
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche EPO Biomarkers Introduction
11.9.4 Roche Revenue in EPO Biomarkers Business (2016-2021)
11.9.5 Roche Recent Development
11.10 Agilent
11.10.1 Agilent Company Details
11.10.2 Agilent Business Overview
11.10.3 Agilent EPO Biomarkers Introduction
11.10.4 Agilent Revenue in EPO Biomarkers Business (2016-2021)
11.10.5 Agilent Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global EPO Biomarkers Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Erythropoietin alfa
Table 3. Key Players of Erythropoietin beta
Table 4. Key Players of Erythropoietin zeta
Table 5. Key Players of Erythropoietin theta
Table 6. Key Players of Recombinant human erythropoietin
Table 7. Key Players of Darbepoietin alfa
Table 8. Global EPO Biomarkers Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global EPO Biomarkers Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global EPO Biomarkers Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global EPO Biomarkers Market Share by Regions (2016-2021)
Table 12. Global EPO Biomarkers Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global EPO Biomarkers Market Share by Regions (2022-2027)
Table 14. EPO Biomarkers Market Trends
Table 15. EPO Biomarkers Market Drivers
Table 16. EPO Biomarkers Market Challenges
Table 17. EPO Biomarkers Market Restraints
Table 18. Global EPO Biomarkers Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global EPO Biomarkers Market Share by Players (2016-2021)
Table 20. Global Top EPO Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in EPO Biomarkers as of 2020)
Table 21. Ranking of Global Top EPO Biomarkers Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by EPO Biomarkers Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players EPO Biomarkers Product Solution and Service
Table 25. Date of Enter into EPO Biomarkers Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global EPO Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 28. Global EPO Biomarkers Revenue Market Share by Type (2016-2021)
Table 29. Global EPO Biomarkers Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global EPO Biomarkers Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global EPO Biomarkers Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global EPO Biomarkers Revenue Market Share by Application (2016-2021)
Table 33. Global EPO Biomarkers Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global EPO Biomarkers Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America EPO Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 36. North America EPO Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America EPO Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 38. North America EPO Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America EPO Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America EPO Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe EPO Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe EPO Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe EPO Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe EPO Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe EPO Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe EPO Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific EPO Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific EPO Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific EPO Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific EPO Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific EPO Biomarkers Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific EPO Biomarkers Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America EPO Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America EPO Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America EPO Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America EPO Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America EPO Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America EPO Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa EPO Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa EPO Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa EPO Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa EPO Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa EPO Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa EPO Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 65. Siemens Company Details
Table 66. Siemens Business Overview
Table 67. Siemens EPO Biomarkers Product
Table 68. Siemens Revenue in EPO Biomarkers Business (2016-2021) & (US$ Million)
Table 69. Siemens Recent Development
Table 70. Thermo Fisher Scientific Company Details
Table 71. Thermo Fisher Scientific Business Overview
Table 72. Thermo Fisher Scientific EPO Biomarkers Product
Table 73. Thermo Fisher Scientific Revenue in EPO Biomarkers Business (2016-2021) & (US$ Million)
Table 74. Thermo Fisher Scientific Recent Development
Table 75. Pfizer Company Details
Table 76. Pfizer Business Overview
Table 77. Pfizer EPO Biomarkers Product
Table 78. Pfizer Revenue in EPO Biomarkers Business (2016-2021) & (US$ Million)
Table 79. Pfizer Recent Development
Table 80. Novartis Company Details
Table 81. Novartis Business Overview
Table 82. Novartis EPO Biomarkers Product
Table 83. Novartis Revenue in EPO Biomarkers Business (2016-2021) & (US$ Million)
Table 84. Novartis Recent Development
Table 85. Johnson & Johnson Company Details
Table 86. Johnson & Johnson Business Overview
Table 87. Johnson & Johnson EPO Biomarkers Product
Table 88. Johnson & Johnson Revenue in EPO Biomarkers Business (2016-2021) & (US$ Million)
Table 89. Johnson & Johnson Recent Development
Table 90. Merck Company Details
Table 91. Merck Business Overview
Table 92. Merck EPO Biomarkers Product
Table 93. Merck Revenue in EPO Biomarkers Business (2016-2021) & (US$ Million)
Table 94. Merck Recent Development
Table 95. LG Life Sciences India Company Details
Table 96. LG Life Sciences India Business Overview
Table 97. LG Life Sciences India EPO Biomarkers Product
Table 98. LG Life Sciences India Revenue in EPO Biomarkers Business (2016-2021) & (US$ Million)
Table 99. LG Life Sciences India Recent Development
Table 100. Amgen Company Details
Table 101. Amgen Business Overview
Table 102. Amgen Revenue in EPO Biomarkers Business (2016-2021) & (US$ Million)
Table 103. Amgen Recent Development
Table 104. Roche Company Details
Table 105. Roche Business Overview
Table 106. Roche EPO Biomarkers Product
Table 107. Roche Revenue in EPO Biomarkers Business (2016-2021) & (US$ Million)
Table 108. Roche Recent Development
Table 109. Agilent Company Details
Table 110. Agilent Business Overview
Table 111. Agilent EPO Biomarkers Product
Table 112. Agilent Revenue in EPO Biomarkers Business (2016-2021) & (US$ Million)
Table 113. Agilent Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global EPO Biomarkers Market Share by Type: 2020 VS 2027
Figure 2. Erythropoietin alfa Features
Figure 3. Erythropoietin beta Features
Figure 4. Erythropoietin zeta Features
Figure 5. Erythropoietin theta Features
Figure 6. Recombinant human erythropoietin Features
Figure 7. Darbepoietin alfa Features
Figure 8. Global EPO Biomarkers Market Share by Application: 2020 VS 2027
Figure 9. Diagnostic centers Case Studies
Figure 10. Ambulatory care and surgical centers Case Studies
Figure 11. Hospitals Case Studies
Figure 12. EPO Biomarkers Report Years Considered
Figure 13. Global EPO Biomarkers Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global EPO Biomarkers Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global EPO Biomarkers Market Share by Regions: 2020 VS 2027
Figure 16. Global EPO Biomarkers Market Share by Regions (2022-2027)
Figure 17. Global EPO Biomarkers Market Share by Players in 2020
Figure 18. Global Top EPO Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in EPO Biomarkers as of 2020
Figure 19. The Top 10 and 5 Players Market Share by EPO Biomarkers Revenue in 2020
Figure 20. Global EPO Biomarkers Revenue Market Share by Type (2016-2021)
Figure 21. Global EPO Biomarkers Revenue Market Share by Type (2022-2027)
Figure 22. North America EPO Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America EPO Biomarkers Market Share by Type (2016-2027)
Figure 24. North America EPO Biomarkers Market Share by Application (2016-2027)
Figure 25. North America EPO Biomarkers Market Share by Country (2016-2027)
Figure 26. United States EPO Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada EPO Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe EPO Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe EPO Biomarkers Market Share by Type (2016-2027)
Figure 30. Europe EPO Biomarkers Market Share by Application (2016-2027)
Figure 31. Europe EPO Biomarkers Market Share by Country (2016-2027)
Figure 32. Germany EPO Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France EPO Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. EPO Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy EPO Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia EPO Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic EPO Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific EPO Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific EPO Biomarkers Market Share by Type (2016-2027)
Figure 40. Asia-Pacific EPO Biomarkers Market Share by Application (2016-2027)
Figure 41. Asia-Pacific EPO Biomarkers Market Share by Region (2016-2027)
Figure 42. China EPO Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan EPO Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea EPO Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia EPO Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India EPO Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia EPO Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America EPO Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America EPO Biomarkers Market Share by Type (2016-2027)
Figure 50. Latin America EPO Biomarkers Market Share by Application (2016-2027)
Figure 51. Latin America EPO Biomarkers Market Share by Country (2016-2027)
Figure 52. Mexico EPO Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil EPO Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa EPO Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa EPO Biomarkers Market Share by Type (2016-2027)
Figure 56. Middle East & Africa EPO Biomarkers Market Share by Application (2016-2027)
Figure 57. Middle East & Africa EPO Biomarkers Market Share by Country (2016-2027)
Figure 58. Turkey EPO Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia EPO Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE EPO Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Siemens Revenue Growth Rate in EPO Biomarkers Business (2016-2021)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in EPO Biomarkers Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in EPO Biomarkers Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in EPO Biomarkers Business (2016-2021)
Figure 65. Johnson & Johnson Revenue Growth Rate in EPO Biomarkers Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in EPO Biomarkers Business (2016-2021)
Figure 67. LG Life Sciences India Revenue Growth Rate in EPO Biomarkers Business (2016-2021)
Figure 68. Amgen Revenue Growth Rate in EPO Biomarkers Business (2016-2021)
Figure 69. Roche Revenue Growth Rate in EPO Biomarkers Business (2016-2021)
Figure 70. Agilent Revenue Growth Rate in EPO Biomarkers Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---